ramucirumab,pembrolizumab
eli lilly,merck
['lcsm,(-blcsm)', 's1800a', 'sclc', 'nsclc', 'ramucirumab', 'pembrolizumab']
 hot off the press, presentation at #asco22 &amp; simultaneous publication by of #s1800a (phase 2 trial) showing os of pembrolizumab + ramucirumab vs soc in advanced #nsclc progressed on io #lcsm
(mos 14.5 vs 11.6 months) article 
Thoracic Oncologist | ViceChair-Education #HemOnc Fellowship Director @MayoClinic FL | Assoc Editor @ASCO Education ?????? ????? #????? ????? #LungCancer #LCSM